Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Matthay, Michael A  [Clear All Filters]
Journal Article
Thébaud B, Matthay MA. Cell Therapy with the Cell or Without the Cell for Premature Infants? Time Will Tell. Am J Respir Crit Care Med. 2021.
Curley GF, O'Kane CM, McAuley DF, Matthay MA, Laffey JG. Cell-based Therapies for ARDS - Where Are We Now?. Am J Respir Crit Care Med. 2024.
Goolaerts A, Pellan-Randrianarison N, Larghero J, Vanneaux V, Uzunhan Y, Gille T, Dard N, Planes CIsabelle, Matthay MA, Clerici C. Conditioned media from mesenchymal stromal cells restores sodium transport and preserves epithelial permeability in an in vitro model of acute alveolar injury. Am J Physiol Lung Cell Mol Physiol. 2014.
Guild J, Juul NH, Andalon A, Taenaka H, Coffey RJ, Matthay MA, Desai TJ. Evidence for lung barrier regeneration by differentiation prior to binucleated and stem cell division. J Cell Biol. 2023;222(12).
Wang C, de Mochel NSReyes, Christenson SA, Cassandras M, Moon R, Brumwell AN, Byrnes LE, Li A, Yokosaki Y, Shan P, et al. Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype. J Clin Invest. 2018.
Fang X, Abbott J, Cheng L, Colby JK, Lee JWoo, Levy BD, Matthay MA. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4. J Immunol. 2015.
Gotts JEarl, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. Am J Physiol Lung Cell Mol Physiol. 2014.
Abreu SCarvalho, Enes SRolandsson, Dearborn J, Goodwin M, Coffey A, Borg ZD, Santos CCDos, Wargo MJ, Cruz FFerreira, Loi R, et al. Lung Inflammatory Environments Differentially Alter Mesenchymal Stromal Cell Behavior. Am J Physiol Lung Cell Mol Physiol. 2019.
Klinger JR, Matthay MA. Mesenchymal Stromal Cell Extracellular Vesicles - A New Approach for Preventing Bronchopulmonary Dysplasia?. Am J Respir Crit Care Med. 2022.
Wick KD, Leligdowicz A, Zhuo H, Ware LB, Matthay MA. Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS. JCI Insight. 2021.
Matthay MA. Therapeutic Potential of Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome. Ann Am Thorac Soc. 2015;12(Supplement 1):S54-S57.